Mucosal immunity and vaccine development

被引:7
|
作者
Anjuere, Fabienne
Czerkinsky, Cecil
机构
[1] Fac Med Pasteur, INSERM, U721, F-06107 Nice 2, France
[2] Fac Med Pasteur, INSERM, U721, F-06107 Nice 2, France
[3] Int Vaccine Inst, Seoul, South Korea
来源
M S-MEDECINE SCIENCES | 2007年 / 23卷 / 04期
关键词
D O I
10.1051/medsci/2007234371
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Mucosae constitute the major entry for most microbial pathogens but also innocuous antigens derived from ingested food, airborne matter or commensal bacteria. A large and highly specialized innate and adaptative mucosal immune system protects the mucosal surfaces and the body interior from potential injuries from the environment. The mucosal immune system has developed a variety of immune mechanisms to discriminate between non-pathogenic and pathogenic invaders. It is able to maintain tolerance against the plethora of environmental antigens and to induce potent protective immunity to avoid mucosal coloniscition and organism invasion by dangerous microbial pathogens, Mucosal immunisation with appropriate antigens and immunostimulatory molecules may induce potent protective immunity against harmful pathogens. Alternatively, mucosally-induced tolerance against auto-antigens or allergens may be generated by mucosal administration of these antigens alone or with immunornodulators potentiating regulatory responses. Here, we review the properties of the mucosal immune system and briefly discuss the advances in the development of mucosal vaccines for protection against infections and for the treatment of inflammatory disorders such as outoimmune diseases or type I allergies.
引用
收藏
页码:371 / 378
页数:8
相关论文
共 50 条
  • [1] The NALT immunity for the development of mucosal vaccine
    Kunisawa, J
    Fukuyama, S
    Sakaue, G
    Hiroi, T
    Kiyono, H
    RECENT ADVANCES IN OTITIS MEDIA, PROCEEDINGS, 2001, : 31 - 35
  • [2] MUCOSAL IMMUNITY - IMPLICATIONS FOR VACCINE DEVELOPMENT
    HOLMGREN, J
    CZERKINSKY, C
    LYCKE, N
    SVENNERHOLM, AM
    IMMUNOBIOLOGY, 1992, 184 (2-3) : 157 - 179
  • [3] Mucosal immunity in sheep and implications for mucosal vaccine development
    McNeilly, T. N.
    McClure, S. J.
    Huntley, J. F.
    SMALL RUMINANT RESEARCH, 2008, 76 (1-2) : 83 - 91
  • [4] MUCOSAL IMMUNITY TO INFECTION WITH IMPLICATIONS FOR VACCINE DEVELOPMENT
    STAATS, HF
    JACKSON, RJ
    MARINARO, M
    TAKAHASHI, I
    KIYONO, H
    MCGHEE, JR
    CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (04) : 572 - 583
  • [5] Mucosal immunity and tolerance: relevance to vaccine development
    Czerkinsky, C
    Anjuere, F
    McGhee, JR
    George-Chandy, A
    Holmgren, J
    Kieny, MP
    Fujiyashi, K
    Mestecky, JF
    Pierrefite-Carle, V
    Rask, C
    Sun, JB
    IMMUNOLOGICAL REVIEWS, 1999, 170 : 197 - 222
  • [6] NEW PERSPECTIVES IN VACCINE DEVELOPMENT - MUCOSAL IMMUNITY TO INFECTIONS
    MCGHEE, JR
    KIYONO, H
    INFECTIOUS AGENTS AND DISEASE-REVIEWS ISSUES AND COMMENTARY, 1993, 2 (02): : 55 - 73
  • [7] EXPLORATION OF MUCOSAL IMMUNITY IN HUMANS - RELEVANCE TO VACCINE DEVELOPMENT
    CZERKINSKY, C
    HOLMGREN, J
    CELLULAR AND MOLECULAR BIOLOGY, 1994, 40 : 37 - 44
  • [8] ROLE OF MUCOSAL SECRETORY IMMUNITY IN THE DEVELOPMENT OF AN AMEBIASIS VACCINE
    RAVDIN, JI
    KELSALL, BL
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1994, 50 (05): : 36 - 41
  • [9] Novel vaccine development strategies for inducing mucosal immunity
    Fujkuyama, Yoshiko
    Tokuhara, Daisuke
    Kataoka, Kosuke
    Gilbert, Rebekah S.
    McGhee, Jerry R.
    Yuki, Yoshikazu
    Kiyono, Hiroshi
    Fujihashi, Kohtaro
    EXPERT REVIEW OF VACCINES, 2012, 11 (03) : 367 - 379
  • [10] NEW PERSPECTIVES IN MUCOSAL IMMUNITY WITH EMPHASIS ON VACCINE DEVELOPMENT
    MCGHEE, JR
    FUJIHASHI, K
    XUAMANO, JC
    JACKSON, RJ
    ELSON, CO
    BEAGLEY, KW
    KIYONO, H
    SEMINARS IN HEMATOLOGY, 1993, 30 (04) : 3 - 15